نتائج البحث - "Isao Fujioka"

1

دورية أكاديمية

Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors

المؤلفون: Yuriko Nishiyama-Fujita, Tomonori Nakazato, Noriyoshi Iriyama, Michihide Tokuhira, Maho Ishikawa, Eriko Sato, Tomoiku Takaku, Keiji Sugimoto, Hiroyuki Fujita, Isao Fujioka, Shun Tsuchiya, Yuta Kimura, Eisaku Iwanaga, Norio Komatsu, Norio Asou, Masahiro Kizaki, Yoshihiro Hatta, Tatsuya Kawaguchi

المصدر: Annals of Medicine, Vol 54, Iss 1, Pp 1244-1254 (2022)

مصطلحات موضوعية: Chronic phase chronic myeloid leukaemia, adolescents and young adults, tyrosine kinase inhibitors, Dasatinib, Nilotinib, Medicine

وصف الملف: electronic resource

Relation: https://doaj.org/toc/0785-3890; https://doaj.org/toc/1365-2060

URL الوصول: https://doaj.org/article/2e6495f34fd84e83afef69bd99b33b59

PDF full text from Publisher

Full Text Finder

2

Bosutinib-induced late-onset severe liver injury preceded by eosinophilia

المؤلفون: Naoki Watanabe, Tomoiku Takaku, Isao Fujioka, Shun Tsuchiya, Miki Ando

المصدر: Annals of hematology. 101(10)

مصطلحات موضوعية: Aniline Compounds, Liver, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Eosinophilia, Nitriles, Quinolines, Humans, Antineoplastic Agents, Hematology, General Medicine, Protein Kinase Inhibitors, Retrospective Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b24467eca3efdd25b029ba1faae27600
https://pubmed.ncbi.nlm.nih.gov/36002756

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

3

The EUTOS long‐term survival score predicts disease‐specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice‐based cohort

المؤلفون: Michihide Tokuhira, Eriko Sato, Norio Asou, Tomoiku Takaku, Hiroyuki Fujita, Yoshihiro Hatta, Tatsuya Kawaguchi, Masahiro Kizaki, Tomonori Nakazato, Noriyoshi Iriyama, Maho Ishikawa, Keiji Sugimoto, Isao Fujioka, Yuta Kimura, Norio Komatsu

المصدر: Cancer Medicine

مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, Time Factors, Fusion Proteins, bcr-abl, Disease, Tyrosine-kinase inhibitor, tyrosine kinase inhibitor, 0302 clinical medicine, Japan, Risk Factors, hemic and lymphatic diseases, Registries, Original Research, Aged, 80 and over, Age specific mortality, Myeloid leukemia, Middle Aged, Progression-Free Survival, Oncology, 030220 oncology & carcinogenesis, Cohort, Disease Progression, Imatinib Mesylate, Female, medicine.drug, Adult, medicine.medical_specialty, Treatment response, Adolescent, medicine.drug_class, Antineoplastic Agents, Risk Assessment, Decision Support Techniques, Young Adult, 03 medical and health sciences, Predictive Value of Tests, chronic myeloid leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Internal medicine, Long term survival, Biomarkers, Tumor, medicine, Humans, Radiology, Nuclear Medicine and imaging, Protein Kinase Inhibitors, Aged, Retrospective Studies, ELTS score, business.industry, Clinical Cancer Research, Imatinib, 030104 developmental biology, prognosis, business, EUTOS

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7648cbe2bcf035e55abe174ff7d1709
https://doi.org/10.1002/cam4.3516

View record at Wiley

Find this article in full text from ProQuest

4

[Microgranular-type acute promyelocytic leukemia with weak myeloperoxidase staining: difficulty of morphological diagnosis]

المؤلفون: Hiroka, Matsuda, Kyohei, Misawa, Tomonori, Ochiai, Isao, Fujioka, Hisayo, Iwasaki, Noriaki, Iwao, Michiaki, Koike, Norio, Komatsu

المصدر: [Rinsho ketsueki] The Japanese journal of clinical hematology. 61(10)

مصطلحات موضوعية: Adult, Leukemia, Promyelocytic, Acute, Staining and Labeling, Humans, Female, Tretinoin, Flow Cytometry, Peroxidase

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::904f4b6f0179cc62e3d0a3ff17ec4fdd
https://pubmed.ncbi.nlm.nih.gov/33162450

5

Smoking influences the outcomes of patients receiving tyrosine kinase inhibitors for chronic myeloid leukemia in the chronic phase: A retrospective analysis

المؤلفون: Eriko Sato, Michihide Tokuhira, Yuta Kimura, Noriyoshi Iriyama, Yoshihiro Hatta, Isao Fujioka, Hiroyuki Fujita, Norio Komatsu, Tomoiku Takaku, Maho Ishikawa, Masahiro Kizaki, Norio Asou, Keiji Sugimoto, Tatsuya Kawaguchi, Tomonori Nakazato

المصدر: Hematological Oncology. 37:323-325

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Myeloid leukemia, Retrospective cohort study, Hematology, General Medicine, medicine.disease, Clinical trial, Myelogenous, Leukemia, Internal medicine, medicine, Retrospective analysis, business, Survival rate, Tyrosine kinase

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::9b9594b65c0d159bdb07de2b359cb813
https://doi.org/10.1002/hon.2617

View record at Wiley

6

Review of clinical case studies of multiracial people

المؤلفون: Isao, Fujioka

المصدر: 心理臨床科学 = Doshisha Clinical Psychology : therapy and research. 7(1):35-48

مصطلحات موضوعية: 人種, 民族, 146.8, マイノリティ, 方法論, 多文化間カウンセリング

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=jairo_______::3b88cebc5788df378b2c48e80c435c6b
http://id.nii.ac.jp/1707/00026089/

7

Introduction of second-generation tyrosine kinase inhibitors may reduce the prognostic impact of high-risk patients, according to the European treatment and outcome study (EUTOS) score

المؤلفون: Keiji Sugimoto, Masahiro Kizaki, Hiroyuki Fujita, Norio Asou, Michihide Tokuhira, Tomonori Nakazato, Eriko Sato, Noriyoshi Iriyama, Tomoiku Takaku, Isao Fujioka, Yoshihiro Hatta, Maho Ishikawa, Norio Komatsu, Tatsuya Kawaguchi

المصدر: Leukemia & Lymphoma. 59:1105-1112

مصطلحات موضوعية: Adult, Male, Research design, Oncology, Cancer Research, medicine.medical_specialty, Adolescent, medicine.drug_class, Tyrosine-kinase inhibitor, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, hemic and lymphatic diseases, Internal medicine, Humans, Medicine, Young adult, Intensive care medicine, Protein Kinase Inhibitors, Survival rate, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Myeloid leukemia, Retrospective cohort study, Imatinib, Hematology, Middle Aged, Protein-Tyrosine Kinases, Prognosis, Europe, Survival Rate, Research Design, 030220 oncology & carcinogenesis, Predictive value of tests, Retreatment, Female, business, Follow-Up Studies, 030215 immunology, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::150f57bc88b02531fdbfcbb73d821ac3
https://doi.org/10.1080/10428194.2017.1365858

PDF full text from Publisher

8

Incidences and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine kinase inhibitors: Surveillance of the CML Cooperative Study Group

المؤلفون: Masahiro Kizaki, Maho Ishikawa, Yoshihiro Hatta, Michihide Tokuhira, Norio Asou, Tomoiku Takaku, Eriko Sato, Tatsuya Kawaguchi, Tomonori Nakazato, Keiji Sugimoto, Hiroyuki Fujita, Noriyoshi Iriyama, Isao Fujioka, Norio Komatsu

المصدر: Leukemia Research. 54:55-58

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Dasatinib, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, hemic and lymphatic diseases, Internal medicine, White blood cell, medicine, Humans, Protein Kinase Inhibitors, neoplasms, Aged, Retrospective Studies, Therapy related, business.industry, Incidence, Clinical course, Myeloid leukemia, Neoplasms, Second Primary, Imatinib, Hematology, Middle Aged, Protein-Tyrosine Kinases, Pyrimidines, Treatment Outcome, 030104 developmental biology, medicine.anatomical_structure, Nilotinib, 030220 oncology & carcinogenesis, Immunology, Imatinib Mesylate, Female, business, Tyrosine kinase, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a612cc4385a1636c3ca492d6087377d5
https://doi.org/10.1016/j.leukres.2017.01.003

View record from ScienceDirect

Full Text via ClinicalKey

9

Potential role for second‑generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia harboring additional clonal chromosome abnormalities: A retrospective CML Cooperative Study Group analysis

المؤلفون: Eriko Sato, Norio Komatsu, Norio Asou, Michihide Tokuhira, Yoshihiro Hatta, Yuta Kimura, Noriyoshi Iriyama, Hiroyuki Fujita, Isao Fujioka, Tatsuya Kawaguchi, Masahiro Kizaki, Maho Ishikawa, Tomoiku Takaku, Keiji Sugimoto, Tomonori Nakazato

المصدر: Oncology reports. 42(6)

مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Adolescent, medicine.drug_class, Philadelphia chromosome, Tyrosine-kinase inhibitor, Disease-Free Survival, Clonal Evolution, Young Adult, hemic and lymphatic diseases, Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, parasitic diseases, medicine, Humans, Philadelphia Chromosome, Survival rate, Protein Kinase Inhibitors, Aged, Aged, 80 and over, Chromosome Aberrations, business.industry, Myeloid leukemia, Cancer, Imatinib, General Medicine, Middle Aged, medicine.disease, Molecular medicine, respiratory tract diseases, Leukemia, Treatment Outcome, Imatinib Mesylate, Female, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6df92d22255758109f970b9d2c2c3c43
https://pubmed.ncbi.nlm.nih.gov/31578586

Find this article in full text from ProQuest

10

Comparison of the clinical outcomes of nilotinib and dasatinib therapies in newly diagnosed patients in the chronic phase of chronic myeloid leukemia: a retrospective analysis

المؤلفون: Michihide Tokuhira, Keiji Sugimoto, Tomoiku Takaku, Noriyoshi Iriyama, Isao Fujioka, Hiroyuki Fujita, Maho Ishikawa, Tatsuya Kawaguchi, Yuta Kimura, Tomonori Nakazato, Norio Asou, Norio Komatsu, Eriko Sato, Yoshihiro Hatta, Masahiro Kizaki

المصدر: Medical oncology (Northwood, London, England). 35(11)

مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Adolescent, medicine.drug_class, Immunology, Dasatinib, Hasford Score, Biochemistry, Tyrosine-kinase inhibitor, law.invention, 03 medical and health sciences, European LeukemiaNet, Young Adult, 0302 clinical medicine, Randomized controlled trial, law, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Protein Kinase Inhibitors, Aged, Retrospective Studies, Aged, 80 and over, Hematology, business.industry, Myeloid leukemia, Imatinib, General Medicine, Cell Biology, Middle Aged, Progression-Free Survival, Imatinib mesylate, Pyrimidines, Treatment Outcome, Nilotinib, 030220 oncology & carcinogenesis, Cohort, Leukemia, Myeloid, Chronic-Phase, Female, business, 030215 immunology, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1abb9c668812db49abc3db59e7499394
https://pubmed.ncbi.nlm.nih.gov/30194496

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

تنقيح النتائج